Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 53 of Hepion Pharmaceuticals, Inc.'s SEC filings and found 11 warrant series, 3 convertibles, 1 shelf registration, 1 S-1 registration and 5 completed offerings on file for HEPA. The latest dilution event on file is an offering on Oct 6, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
KYNBKyntra Bio, Inc.
QNTMQuantum BioPharma Ltd.
ESLAEstrella Immunopharma, Inc.
PLURPluri Inc. Common Stock
MCRBSeres Therapeutics, Inc.
CNTXContext Therapeutics Inc.
JSPRJasper Therapeutics, Inc.
AEONAEON Biopharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
AKTXAkari Therapeutics, Plc
BOLTBolt Biotherapeutics, Inc.
ALLRAllarity Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
ACTUActuate Therapeutics Inc
MRKRMarker Therapeutics, Inc.